| Benzoporphyrin derivative monoacid ring A (BPD-MA), vertoporfin |
689 nm |
Subjects with non-facial PWS |
Tournas JA, Lai J, Truitt A et al. [33]. |
2009 |
| Tumor tissue in a mouse tumor model |
Richter AM, Waterfield E, Jain AK et al. [97]. |
1993 |
| Meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) |
|
Osteosarcoma cells |
Duchi S, Sotgiu G, Lucarelli E et al. [98]. |
2013 |
| N-aspartyl chlorin e6, NPe6 |
660 nm |
7 patients with bile duct carcinoma |
Nanashima A, Abo T, Nonaka T, et al.[99]. |
2012 |
| Aminolevulinic acid (5-ALA) |
635 nm |
9 patients with deep-seated contrast enhancing brain tumors |
Rapp M, Kamp M, Steiger HJ, et al. [100]. |
2014 |
| Patients with suspected malignant gliomas |
Díez Valle R, Slof J, Galván J, et al.[101]. |
2014 |
| Temoporfin or m-THPC (Foscan(®)) |
652 nm |
Rat model employing a radioactive lipid label and (14)C-temoporfin. |
Decker C, Schubert H, May S, et al. [102]. |
2013 |
| TSPP |
— |
Wistar male rats bearing 256 Walker carcinosarcoma |
Clichici S, Filip A, Daicoviciu D, et al. [28]. |
2010 |
| HPPH |
|
Mice and rat tumor models |
Spernyak J A, White III W H, Ethirajan M, et al. [103]. |
2010 |
